title: Global developmental delay in guanidionacetate methyltransferase deficiency: differences in formal testing and clinical observation.
abstract: Guanidinoacetate N-methyltransferase (GAMT) deficiency is a defect in the biosynthesis of creatine (Cr). So far, reports have not focused on the description of developmental abilities in this disorder. Here, we present the result of formal testing of developmental abilities in a GAMT-deficient patient. Our patient, a 3-year-old boy with GAMT deficiency, presented clinically with a severe language production delay and nearly normal nonverbal development. Treatment with oral Cr supplementation led to partial restoration of the cerebral Cr concentration and a clinically remarkable acceleration of language production development. In contrast to clinical observation, formal testing showed a rather harmonic developmental delay before therapy and a general improvement, but no specific acceleration of language development after therapy. From our case, we conclude that in GAMT deficiency language delay is not always more prominent than delays in other developmental areas. The discrepancy between the clinical impression and formal testing underscores the importance of applying standardized tests in children with developmental delays. Screening for Cr deficiency by metabolite analysis of body fluids or proton magnetic resonance spectroscopy of the brain deficiency should be considered in any child with global developmental delay/mental retardation lacking clues for an alternative etiology.
authors.affiliation: University Medical Center Groningen, Beatrix Children's Hospital, University of Groningen, Groningen, The Netherlands. k.t.verbruggen@bkk.umcg.nl
authors.forename: Krijn T
authors.initials: KT
authors.lastname: Verbruggen
authors.forename: Wilma A
authors.initials: WA
authors.lastname: Knijff
authors.forename: Roelineke J
authors.initials: RJ
authors.lastname: Soorani-Lunsing
authors.forename: Paul E
authors.initials: PE
authors.lastname: Sijens
authors.forename: Nanda M
authors.initials: NM
authors.lastname: Verhoeven
authors.forename: Gajja S
authors.initials: GS
authors.lastname: Salomons
authors.forename: Siena M
authors.initials: SM
authors.lastname: Goorhuis-Brouwer
authors.forename: Francjan J
authors.initials: FJ
authors.lastname: van Spronsen
mesh_terms: D000596:Amino Acids / Q000008:administration & dosage; D002675:Child, Preschool; D003401:Creatine / Q000008:administration & dosage; D002658:Developmental Disabilities / Q000175:diagnosis / Q000188:drug therapy / Q000209:etiology*; D050937:Guanidinoacetate N-Methyltransferase / Q000172:deficiency*; D006801:Humans; D007805:Language Development Disorders / Q000175:diagnosis / Q000188:drug therapy / Q000209:etiology*; D008297:Male; D008661:Metabolism, Inborn Errors / Q000150:complications* / Q000175:diagnosis / Q000188:drug therapy
chemical_list: D000596:Amino Acids; D050937:Guanidinoacetate N-Methyltransferase; D003401:Creatine